专访丨对话酶赛生物陈海滨：宁波走出的合成生物学国际新势力

Core Viewpoint - Enzyme Science is transitioning from a technology service company to a technology-driven product company, focusing on the commercialization of over 20 products in various fields, including pharmaceutical intermediates and bio-based materials, with an expected revenue doubling this year [2][4]. Company Positioning and Development History - Enzyme Science started as a technology service company in 2013, focusing on biocatalysis and enzyme catalysis within the framework of green chemistry, aligning with national policies on environmental protection [5][6]. - The company has evolved to integrate its core technology capabilities from enzyme catalysis to metabolic engineering and chemical synthesis, achieving a market-oriented integration of research, production, and sales [5][6]. Business Structure and Strategic Direction - The company has a dual business structure, focusing on high-margin pharmaceutical intermediates and lower-margin bio-based materials, ensuring resource allocation and capability synergy for long-term growth [9][10]. - Enzyme Science has commercialized over ten pharmaceutical intermediates, including products for cholesterol and diabetes treatment, and aims to reduce synthesis costs significantly to gain market advantages [10][11]. Financing and Cash Flow - The company has completed its C-round financing, indicating a stable commercial phase, with future financing aimed at expanding production capacity and enhancing profitability [13][14]. Technological Advancements - Enzyme Science has upgraded its technology platforms, including high-throughput sequencing and AI-driven enzyme design, to enhance data accumulation and experimental efficiency [15][16][18]. - The company emphasizes the importance of high-quality data in enzyme engineering, with a database containing over 500,000 high-quality data points to improve development success rates [18][19]. Production Capacity and Product Combination - The company operates a 10,000-liter enzyme preparation factory, focusing on maximizing capacity utilization to avoid idle production, which can increase costs [25][26]. - Product planning is driven by customer orders, ensuring production aligns with market demand while maintaining quality and delivery timelines [25][26]. Bio-based Product Layout - Enzyme Science is strategically developing bio-based products like glucaric acid, which is positioned as a structural alternative to traditional petrochemical routes, leveraging its biological manufacturing capabilities [27][30]. - The company recognizes the need for market education for new products, which may require longer development cycles compared to mature products [28][29].